Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings - PubMed (original) (raw)
Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings
G Orozco et al. J Neurol Sci. 1989 Oct.
Abstract
A form of dominantly inherited olivopontocerebellar atrophy (OPCA) occurs commonly in persons of Spanish ancestry in northeastern Cuba. Its prevalence in the Province of Holguin is 41 per 100,000, a figure much higher than that found in western Cuba or in other parts of the world. The high prevalence is probably the result of a founder effect, but might be due to an interaction between a mutant gene and an unidentified environmental neurotoxin. We describe the clinical features of this disorder, and the neuropathological abnormalities in 7 autopsied patients. In addition, we report biochemical findings in plasma, cerebrospinal fluid (CSF) and urine obtained from 10 living OPCA patients. Quantitation of amino acids in fasting plasma showed a number of differences between the Cuban patients and healthy Canadian controls, but these are likely to have been caused by dietary differences. Amino acid concentrations in the CSF of the Cuban OPCA patients were similar to those of healthy Cuban controls, except for a decreased concentration of ethanolamine. Mean concentrations of dopamine metabolites were significantly low in the CSF of the OPCA patients, corresponding to neuronal depletion observed in the substantia nigra of autopsied cases. Examination of the patients' urines provided no evidence that either cyanide or 3-acetylpyridine is involved in causing this form of OPCA.
Similar articles
- Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies.
Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G. Estrada R, et al. Acta Neuropathol. 1999 Mar;97(3):306-10. doi: 10.1007/s004010050989. Acta Neuropathol. 1999. PMID: 10090679 - Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy.
Kish SJ, Schut L, Simmons J, Gilbert J, Chang LJ, Rebbetoy M. Kish SJ, et al. J Neurol Neurosurg Psychiatry. 1988 Apr;51(4):544-8. doi: 10.1136/jnnp.51.4.544. J Neurol Neurosurg Psychiatry. 1988. PMID: 3164041 Free PMC article. - Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy.
Kish SJ, Robitaille Y, el-Awar M, Deck JH, Simmons J, Schut L, Chang LJ, DiStefano L, Freedman M. Kish SJ, et al. Ann Neurol. 1989 Sep;26(3):362-7. doi: 10.1002/ana.410260309. Ann Neurol. 1989. PMID: 2802535 - Infantile olivopontocerebellar atrophy with spinal muscular atrophy (infantile OPCA + SMA).
Chou SM, Gilbert EF, Chun RW, Laxova R, Tuffli GA, Sufit RL, Krassikot N. Chou SM, et al. Clin Neuropathol. 1990 Jan-Feb;9(1):21-32. Clin Neuropathol. 1990. PMID: 2407400 Review. - Machado-Joseph disease: an autosomal dominant motor system degeneration.
Rosenberg RN. Rosenberg RN. Mov Disord. 1992;7(3):193-203. doi: 10.1002/mds.870070302. Mov Disord. 1992. PMID: 1620135 Review.
Cited by
- Hereditary Cerebellar Ataxias: A Korean Perspective.
Kim JS, Cho JW. Kim JS, et al. J Mov Disord. 2015 May;8(2):67-75. doi: 10.14802/jmd.15006. Epub 2015 May 31. J Mov Disord. 2015. PMID: 26090078 Free PMC article. Review. - TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2.
Bux J, Sen NE, Klink IM, Hauser S, Synofzik M, Schöls L, Auburger G, Riess O, Hübener-Schmid J. Bux J, et al. Mol Neurobiol. 2023 Jun;60(6):3553-3567. doi: 10.1007/s12035-023-03294-y. Epub 2023 Mar 9. Mol Neurobiol. 2023. PMID: 36894829 Free PMC article. - Population based study of late onset cerebellar ataxia in south east Wales.
Muzaimi MB, Thomas J, Palmer-Smith S, Rosser L, Harper PS, Wiles CM, Ravine D, Robertson NP. Muzaimi MB, et al. J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1129-34. doi: 10.1136/jnnp.2003.014662. J Neurol Neurosurg Psychiatry. 2004. PMID: 15258214 Free PMC article. - Spinocerebellar ataxia type 2 (SCA2): identification of early brain degeneration in one monozygous twin in the initial disease stage.
Hoche F, Balikó L, den Dunnen W, Steinecker K, Bartos L, Sáfrány E, Auburger G, Deller T, Korf HW, Klockgether T, Rüb U, Melegh B. Hoche F, et al. Cerebellum. 2011 Jun;10(2):245-53. doi: 10.1007/s12311-010-0239-9. Cerebellum. 2011. PMID: 21128038 - Degenerative ataxias, from genes to therapies: The 2015 Cotzias Lecture.
Pulst SM. Pulst SM. Neurology. 2016 Jun 14;86(24):2284-90. doi: 10.1212/WNL.0000000000002777. Neurology. 2016. PMID: 27298447 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical